Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 3Stomach Neoplasms 2Sarcoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Smoking Cessation 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Neurofibrosarcoma 1Neoplasm Metastasis 1Mucopolysaccharidosis I 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Glioblastoma 1Fibrosarcoma 1Colorectal Neoplasms 1Cachexia 1Breast Neoplasms 1

Interventions

Prospective Studies 1Phlebotomy 1Paclitaxel 1Follow-Up Studies 1Combined Modality Therapy 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Cancer Vaccines 1Biological Specimen Banks 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mucopolysaccharidosis I × Combined Modality Therapy × Clear all
NCT03411161 2021-05-25

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Servier

Phase 1/2 Completed
22 enrolled
Breast

Breast Neoplasms, Mucopolysaccharidosis I, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡